DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Omiganan is an investigational drug.
There have been 13 clinical trials for Omiganan. The most recent clinical trial was a Phase 3 trial, which was initiated on October 1st 2015.
The most common disease conditions in clinical trials are Rosacea, Dermatitis, and Eczema. The leading clinical trial sponsors are Cutanea Life Sciences, Inc., Mallinckrodt, and Leiden University Medical Center.
Recent Clinical Trials for Omiganan
|Omiganan Twice a Day (BID) in Patients With Facial Seborrheic Dermatitis||Cutanea Life Sciences, Inc.||Phase 2|
|Pharmacodynamics of Omiganan BID in Patients With Atopic Dermatitis||Cutanea Life Sciences, Inc.||Phase 2|
|Topical Challenge With Omiganan and Imiquimod in Healthy Volunteers||Cutanea Life Sciences, Inc.||Phase 1|